Bioventus Inc (BVS)
11.71
+0.20
(+1.74%)
USD |
NASDAQ |
Nov 22, 16:00
11.76
+0.05
(+0.43%)
After-Hours: 20:00
Bioventus Cash from Operations (Quarterly): 10.32M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.32M |
| June 30, 2024 | 15.16M |
| March 31, 2024 | -6.005M |
| December 31, 2023 | 10.37M |
| September 30, 2023 | -8.315M |
| June 30, 2023 | 10.80M |
| March 31, 2023 | 2.49M |
| December 31, 2022 | 5.244M |
| September 30, 2022 | -0.701M |
| June 30, 2022 | 2.939M |
| March 31, 2022 | -21.02M |
| Date | Value |
|---|---|
| December 31, 2021 | 13.12M |
| September 30, 2021 | 10.59M |
| June 30, 2021 | 17.33M |
| March 31, 2021 | -18.04M |
| December 31, 2020 | 25.45M |
| September 30, 2020 | 20.84M |
| June 30, 2020 | 7.82M |
| March 31, 2020 | 17.69M |
| March 31, 2016 | 2.162M |
| March 31, 2015 | -3.821M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-21.02M
Minimum
Mar 2022
25.45M
Maximum
Dec 2020
6.109M
Average
10.32M
Median
Sep 2024
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp | 1.002B |
| Insulet Corp | 98.50M |
| Perspective Therapeutics Inc | 3.366M |
| Xtant Medical Holdings Inc | -1.718M |
| Catheter Precision Inc | -2.768M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.064M |
| Cash from Financing (Quarterly) | 0.362M |
| Free Cash Flow | 29.05M |
| Free Cash Flow Per Share (Quarterly) | 0.1571 |
| Free Cash Flow to Equity (Quarterly) | 9.947M |
| Free Cash Flow to Firm (Quarterly) | 20.95M |
| Free Cash Flow Yield | 3.88% |